Volume and trends of adalimumab and pembrolizumab reimbursed market: the Bulgarian perspective
The global market of monoclonal antibodies (mAbs) is growing very fast. The aim of this study is to analyze the reimbursed market of adalimumab and pemborlizumab in Bulgaria. A retrospective cost analysis of the reimbursed mAbs adalimumab and pemborlizumab for ambulatory and hospital settings, respe...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-01-01
|
| Series: | Biotechnology & Biotechnological Equipment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/13102818.2021.2019116 |